The CVC HeartBeat: All the latest information about heart health and wellness from the experts at the University of Michigan Frankel Cardiovascular Center, nationally ranked for heart care by U.S. News & World Report. To make an appointment, call us at 1-888-287-1082.
An implantable cardioverter defibrillator, or ICD, provides immediate therapy to life-threatening arrhythmias (heart beating too quickly or too slowly) through a painless pacing sequence or a jolt of electricity. Despite its lifesaving capabilities, an ICD may bring questions, fear and anxiety for many patients.
Here are three questions I’m often asked by ICD patients:
Q. What about airport security scanners and other magnetic devices? Will they interact with my ICD?
External electromagnetic or radiofrequency signals can impact an ICD, so patients should not stand in or near the doorway of stores with electronic theft-detection devices or in airport security areas. Instead, show your ICD identification card and ask to be hand searched at airports or other places with electronic security areas (sports venues, etc.). Also, cellular telephones shouldn’t be held on the side where your ICD has been implanted. Instead, use your opposite ear when talking. X-rays, including mammograms, are permitted.Continue reading →
University of Michigan cardiologist Dr. G. Michael Deeb wants his patients to know something: Nicotine is toxic not only to the lungs but also to the heart. “When most patients think of the dangers of smoking, they think about the lungs,” says Dr. Deeb. “But cardiovascular disease is the number one killer in Michigan, and smoking is accelerating the problem.”
According to theAmerican Heart Association, as many as 30 percent of all coronary heart disease deaths in the United States each year are attributable to cigarette smoking, and the more you smoke, the greater your risk. But even people who smoke fewer than five cigarettes a day can have early signs of cardiovascular disease.Continue reading →
A new app designed to monitor symptoms associated with atrial fibrillation, or Afib, is being evaluated as part of a University of Michigan study. Developed by U-M cardiologist Dr. Hamid Ghanbari, “miAfib” allows patients to more accurately communicate their atrial fibrillation symptoms in real time.
Tracking Afib sypmtoms
Atrial fibrillation is the most prevalent major arrhythmia in the United States. It can lead to an increased risk of stroke, congestive heart failure and overall mortality. What is much less certain, says Dr. Ghanbari, is the association between Afib symptoms, affect and heart rhythm on a daily basis.Continue reading →
The American Heart Association reports that while an estimated 10 percent of Americans ages 18 and older acknowledge depression, up to 33 percent of heart attack patients develop some degree of depression.
Dr. Michelle Riba, professor of psychiatry and associate chair for U-M’s Integrated Medical and Psychiatric Services in the Department of Psychiatry and associate director of the U-M Comprehensive Depression Center, takes it a step further: “It’s very complicated,” she says, noting that“almost every major cardiac condition has psychological issues that need to be addressed.” Monitoring a heart patient’s mental health is just as important as treating his or her physical condition, she says.
It gets even more complicated, says Dr. Riba, because not only can cardiovascular disease lead to depression, but also depression can lead to cardiovascular disease. “It’s bidirectional.”
Atrial fibrillation, or Afib, is the most commoncardiac arrhythmia, resulting in a fast or irregular heart rhythm among more than 5 million Americans. Afib is traditionally treated with blood-thinners or anticoagulants such as warfarin, but a new device, recently approved by the FDA, is changing the way Afib is treated.
The WATCHMAN™ Left Arial Appendage Closure Deviceoffers patients with non-valvular atrial fibrillation a potentially life-changing stroke risk treatment option that could free them from the challenges of long-term warfarin therapy.
The Frankel Cardiovascular Center is among the first heart centers in the nation to use the WATCHMAN Device. With stroke being one of the most feared consequences of Afib, the WATCHMAN Device has proved to be a viable alternative to blood-thinning medications, which are not well-tolerated by some patients and have a significant risk for bleeding complications.Continue reading →
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.